Free Trial

Astera Labs, Inc. $ALAB Shares Sold by Exchange Traded Concepts LLC

Astera Labs logo with Computer and Technology background

Key Points

  • Exchange Traded Concepts LLC reduced its holdings in Astera Labs, Inc. by 17.7%, owning 39,838 shares worth approximately $3.6 million after selling 8,546 shares in the second quarter.
  • A variety of institutional investors increased their positions in Astera Labs significantly in the first quarter, with Alliancebernstein L.P. boosting its holdings by 114.2% and Bank of Nova Scotia by an astonishing 3,742.2%.
  • Astera Labs reported a 149.5% increase in revenue year-over-year, with $191.93 million for the quarter, and earnings per share of $0.44, outperforming analysts' expectations of $0.33.
  • Interested in Astera Labs? Here are five stocks we like better.

Exchange Traded Concepts LLC lowered its stake in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 17.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 39,838 shares of the company's stock after selling 8,546 shares during the quarter. Exchange Traded Concepts LLC's holdings in Astera Labs were worth $3,602,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the stock. Cetera Investment Advisers acquired a new position in shares of Astera Labs in the 4th quarter worth approximately $460,000. Deutsche Bank AG raised its position in Astera Labs by 33.0% in the fourth quarter. Deutsche Bank AG now owns 7,695 shares of the company's stock valued at $1,019,000 after purchasing an additional 1,909 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in Astera Labs during the fourth quarter worth $1,543,000. Quantinno Capital Management LP acquired a new position in Astera Labs during the fourth quarter worth $548,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of Astera Labs by 2,824.4% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 154,524 shares of the company's stock worth $20,467,000 after buying an additional 149,240 shares during the period. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on ALAB. Evercore ISI boosted their price objective on Astera Labs from $104.00 to $215.00 and gave the company an "outperform" rating in a report on Wednesday, August 6th. Barclays reaffirmed an "overweight" rating and issued a $155.00 target price (up from $75.00) on shares of Astera Labs in a research report on Thursday, August 7th. Morgan Stanley increased their price target on shares of Astera Labs from $155.00 to $200.00 and gave the stock an "overweight" rating in a research report on Friday, August 29th. Citigroup lifted their price objective on shares of Astera Labs from $160.00 to $275.00 and gave the company a "buy" rating in a report on Wednesday, September 17th. Finally, Stifel Nicolaus set a $145.00 target price on shares of Astera Labs and gave the stock a "buy" rating in a research note on Monday, August 4th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $152.94.

Check Out Our Latest Report on Astera Labs

Insider Transactions at Astera Labs

In other Astera Labs news, Director Manuel Alba sold 183,000 shares of the company's stock in a transaction on Tuesday, September 2nd. The shares were sold at an average price of $173.27, for a total value of $31,708,410.00. Following the completion of the transaction, the director owned 385,863 shares in the company, valued at $66,858,482.01. This represents a 32.17% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Jitendra Mohan sold 91,441 shares of the firm's stock in a transaction dated Monday, August 18th. The stock was sold at an average price of $183.51, for a total value of $16,780,337.91. Following the transaction, the chief executive officer directly owned 2,170,877 shares in the company, valued at approximately $398,377,638.27. The trade was a 4.04% decrease in their position. The disclosure for this sale can be found here. Insiders sold 1,576,713 shares of company stock valued at $239,237,016 over the last quarter. 12.50% of the stock is owned by corporate insiders.

Astera Labs Stock Down 3.2%

ALAB traded down $7.90 on Monday, reaching $237.30. The company's stock had a trading volume of 6,356,998 shares, compared to its average volume of 5,073,114. The company has a market capitalization of $39.44 billion, a price-to-earnings ratio of 423.75, a P/E/G ratio of 6.22 and a beta of 1.46. Astera Labs, Inc. has a fifty-two week low of $47.13 and a fifty-two week high of $262.90. The stock has a 50 day moving average of $169.95 and a two-hundred day moving average of $110.12.

Astera Labs (NASDAQ:ALAB - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported $0.44 earnings per share for the quarter, topping analysts' consensus estimates of $0.33 by $0.11. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The company had revenue of $191.93 million for the quarter, compared to analysts' expectations of $172.46 million. During the same quarter last year, the company earned $0.13 earnings per share. The firm's revenue for the quarter was up 149.5% on a year-over-year basis. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. As a group, analysts anticipate that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

About Astera Labs

(Free Report)

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

See Also

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Should You Invest $1,000 in Astera Labs Right Now?

Before you consider Astera Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.

While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.